EyePoint (EYPT) Pharmaceuticals announced that it has commenced an underwritten public offering of $150M of shares of its common stock. All of the shares are being offered by EyePoint. J.P. Morgan, Jefferies, Citigroup, and Guggenheim Securities are acting as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYPT:
- EyePoint Pharmaceuticals Launches Phase 3 DURAVYU Program
- EyePoint files automatic mixed securities shelf
- EyePoint initiates Duravyu program, announces preclinical vorolanib data
- EyePoint reports inducement grants under NASDAQ listing rule
- EyePoint Pharmaceuticals Completes Promising Study on EYP-1901 for Diabetic Retinopathy